Related Experiment Video
Updated: May 15, 2026

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Infantile malignant osteopetrosis: a rare cause of neonatal hypocalcemia
Ozlem Engiz1, Semra Kara, Denizhan Bagrul
1Department of Pediatric Endocrinology, Ankara Training and Research Hospital, Ankara, Turkey. oengiz@yahoo.com
Insights
Infantile malignant osteopetrosis (IMO) can cause neonatal hypocalcemia, a critical sign often missed by clinicians. Early diagnosis of this rare bone disorder is vital for timely treatment and improved outcomes.
Area of Science:
- Genetics
- Pediatrics
- Bone Biology
Background:
- Infantile malignant osteopetrosis (IMO) is a rare genetic disorder affecting osteoclast function, leading to bone overgrowth.
- IMO typically manifests in early infancy with symptoms including anemia, vision/hearing loss, and fractures.
Observation:
- A case report details an infant presenting with neonatal hypocalcemia and characteristic radiographic findings of IMO.
- The infant later developed pancytopenia and severe bilateral optic nerve damage.
Findings:
- Genetic analysis identified a novel mutation in the TCIRG1 gene in the affected infant.
- This case highlights neonatal hypocalcemia as a potential early indicator of IMO.
Implications:
- Recognizing neonatal hypocalcemia as a symptom of IMO is crucial for prompt diagnosis and intervention.
- Early detection can prevent severe complications and improve the prognosis for infants with infantile malignant osteopetrosis.
Abstract:
Infantile malignant osteopetrosis (IMO; OMIM 259700) is a rare inherited bone disease characterized by reduced or dysregulated activity of osteoclasts, resulting in generalized osteosclerosis. The disease usually presents within the first few months of life with anemia, hepatosplenomegaly, frontal bossing, nystagmus, blindness, deafness, and bone fractures. Children with IMO are at risk of developing hypocalcemia, with attendant tetanic seizures. We report the case of a baby boy who presented with neonatal hypocalcemia. Skeletal radiographs demonstrated sclerotic bones and a dense base of the skull with typical "space alien" face confirming the diagnosis of IMO. Pancytopenia developed at 2 months of age. Visual evoked potential showed severe bilateral optic nerve damage. Genetic mutation study revealed a new mutation in exon 13 of the TCIRG1 gene. Neonatal hypocalcemia can occur as result of IMO, which is easily missed out by clinicians. This causes delay in establishing the diagnosis and starting necessary treatment. Therefore, osteopetrosis should be kept in mind as a rare cause of neonatal hypocalcemia.
Related Concept Videos
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Inborn Errors of Metabolism
Skeleton and Calcium Homeostasis
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Introduction to Electrolytes
Role of Sodium
One...